Shopping Cart
- Remove All
- Your shopping cart is currently empty
Suciraslimab (SM03) is a human IgG1 monoclonal antibody against the B-cell restriction antigen CD22 for the treatment of rheumatoid arthritis (RA) and other B-cell related diseases.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $247 | In Stock | |
5 mg | $619 | In Stock | |
10 mg | $953 | In Stock | |
25 mg | $1,390 | In Stock | |
50 mg | $1,880 | In Stock |
Description | Suciraslimab (SM03) is a human IgG1 monoclonal antibody against the B-cell restriction antigen CD22 for the treatment of rheumatoid arthritis (RA) and other B-cell related diseases. |
In vivo | In 5xFAD Alzheimer's disease mouse models, intraperitoneal injection of Suciraslimab (10 mg/kg, once weekly for 4 weeks) significantly enhanced microglial metabolic activity and phagocytosis, reduced brain amyloid plaque burden, and upregulated neuroprotective gene expression[1]. |
Alias | SM03, SM 03 |
Cas No. | 2415439-63-1 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.